CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $2.84M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$63.4K | |
| 2 | +$31.3K | |
| 3 | +$28.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.18K |
Top Sellers
| 1 | -$46.4K | |
| 2 | -$10.7K | |
| 3 | -$2.01K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$221 |
| 5 |
CFM
Catalyst Funds Management
Sydney NSW,
Australia
|
-$93 |